NEW YORK – Rapid in vitro diagnostic maker Biolytical recently received prequalification status from the World Health Organization for its 60-second HIV self-test to detect antibodies to the virus directly from whole blood finger-stick samples. The firm has also begun a national collaboration to evaluate HIV self-testing in Canada that will ultimately support regulatory efforts there, and it is looking into the home-use regulatory pathway in the US as well.